Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 16 results for "astrazeneca"

AstraZeneca's immunotherapy drug gets US FDA nod for lung cancer treatment
Business Standard

AstraZeneca wins U.S. approval for 1st-line use of lung cancer...

(Reuters) - U.S. regulators have expanded use of AstraZeneca's lung cancer drug Tagrisso to include initial treatment of patients with a specific genetic mutation, the company said on Wednesday. Reuters, 14 hours ago

13 images for astrazeneca

Business Standard, 1 day ago
Money Control, 2 days ago
Money Control, 2 days ago
Money Control, 1 month ago
Business Standard, 2 months ago
Money Control, 5 months ago
Money Control, 5 months ago
Money Control, 4 months ago
Money Control, 4 months ago
Money Control, 6 months ago
Money Control

Astrazeneca Pharma firms up after announcing investment in India

after parent, AstraZeneca, announced its decision of further investing $90 million over the next 5 years in India. The announcement was made after market hours yesterday, 17 April 2018. Meanwhile, the S BSE Sensex was up 19.61 points, or 0.06% to 34,414.67.
 Business Standard1 day ago Astrazeneca Pharma jumps after announcing investment in India  Business Standard1 day ago AstraZeneca to invest Rs 600 crore in India over next 5 years  Money Control2 days ago

Astrazeneca Pharma India schedules board meeting

First Published: Sat, January 20 2018. 11:57 IST RECOMMENDED FOR YOU RECOMMENDED FOR YOU
 Business Standard2 months ago

Ionis may get up to $300 million in licensing deal with AstraZeneca

(Reuters) - Ionis Pharmaceuticals Inc said on Monday a licensing deal for its fatty liver disease treatment with AstraZeneca Plc could fetch up to $300 million in milestone payments.
 Reuters1 week ago

U.S. health officials reverse stance on AstraZeneca's flu vaccine

(Reuters) - AstraZeneca Plc said on Wednesday an advisory committee of the U.S. Centers for Disease Control and Prevention recommended the use of its FluMist Quadrivalent vaccine in the upcoming flu season, reversing its earlier position.
 Reuters1 month ago

AstraZeneca is sued by Array BioPharma over cancer drug royalties

NEW YORK (Reuters) - Array BioPharma Inc on Thursday sued AstraZeneca AB, accusing the pharmaceutical company of refusing to pay required royalties for a cancer drug after entering into an $8.5 billion collaboration with Merck & Co.
 Reuters2 months ago

AstraZeneca's three-in-one inhaler helps COPD patients in trial

(Reuters) - AstraZeneca said an inhaler for chronic obstructive pulmonary disease (COPD) delivered improved lung function in a late stage trial that could challenge GlaxoSmithKline's new three-in-one inhaler.
 Reuters2 months ago

AstraZeneca flags return to drug sales growth in 2018

expects to increase drug sales at a low single-digit percentage rate this year as new medicines win market share and the company puts patent losses behind it, although the need to invest in launches will weigh on profit. Product sales fell 5 percent in 2017, ...
 Business Standard2 months ago AstraZeneca profit outlook disappoints, despite drug sales growth  Business Standard2 months ago
Business Standard

Manipal Global wins Silver Award at LPI Learning Awards 2018

Manipal Global Education Services (MaGE) has bagged the Silver Award at the Learning Awards 2018, for their contribution in the Digital Learning Transformation Category. This award ceremony was hosted by the Learning and Performance Institute (LPI) at the ...
 Business Standard2 months ago
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less